We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Boston, USA
855 Boylston Street, 11th Floor
Boston, MA, 02116
USA

People

CEO & Board of Directorse
President & Founder
BOARD OF DIRECTORS
Board of Directors
Chief Development Officer & Founder
Chief Scientific Officer

Funding

TOTAL $94.9M
FUNDING TOTAL $94.9M
Series A, 3/2010
MPM Capital
New Enterprise Associates
$21M
Series A, 9/2010
$19M
Venture Round, 6/2012
$9.5M
Series B, 6/2012
MPM Capital
New Enterprise Associates
Third Rock Ventures
Ipsen
$25M
Series B, 11/2012
Pfizer Venture Investments
MPM Capital
New Enterprise Associates
Third Rock Ventures
Ipsen
$8M
Series B, 7/2013
$11M
Grant, 9/2013
The Michael J. Fox Foundation
$1.4M

Tags

Rhythm Pharmaceuticals

Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.

Recent Milestones

Videos

Screenshots

Sources

  1. Rhythm Pharma raises $21M for metabolic diseases (fiercebiotech.com) [edit]
  2. Rhythm Adds $19M to Series A Round to Advance Peptide-Based Drugs (genengnews.com) [edit]
  3. Rhythm Pharma sells $9.5M in equity financing (masshightech.com) [edit]
  4. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics (rhythmtx.com) [edit]
  5. Rhythm Adds $8M to Cap Series B at $33M (pehub.com) [edit]
  6. Rhythm Lands $11 Million Tranche to Advance Its Treatment of GI Disorders (biospace.com) [edit]
  7. Rhythm awarded $1.4M Michael J. Fox Foundation grant (bizjournals.com) [edit]
Edit This Page
Last Edited 4/10/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy